Young-onset versus late-onset colorectal cancer: clinicopathological features and survival outcome: a decade-long analysis from a middle Eastern tertiary center.
Ammar Aleter, Ali Toffaha, Ejaz Ahmed Latif, Mahwish Khawar, Ibrahim Amer, Samer A Hasan, Mahmood Al-Dhaheri, Ayman Ahmed, Ayman El-Menyar, Mohamed Abu Nada, Amjad Parvaiz
{"title":"Young-onset versus late-onset colorectal cancer: clinicopathological features and survival outcome: a decade-long analysis from a middle Eastern tertiary center.","authors":"Ammar Aleter, Ali Toffaha, Ejaz Ahmed Latif, Mahwish Khawar, Ibrahim Amer, Samer A Hasan, Mahmood Al-Dhaheri, Ayman Ahmed, Ayman El-Menyar, Mohamed Abu Nada, Amjad Parvaiz","doi":"10.1186/s12957-025-04010-x","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Colorectal cancer (CRC) incidence is reported to be declining overall in many countries but growing among young adults. The updated American Cancer Society (ACS) guidelines recommend screening starting at age 45 years. We sought to evaluate population-level trends in young colorectal cancer (yCRC) epidemiology in Qatar, a country in the Middle East.</p><p><strong>Methods: </strong>Between January 2010 and December 2020, we included 1529 patients from the National Registry Database with a 5-year follow-up. The patients were divided into two groups. Group 1 (n = 380, ≤ 45 years) and group 2 (n = 1149, > 45). The epidemiological and clinicopathological features were analyzed and compared in the two groups.</p><p><strong>Results: </strong>The annual incidence rate of CRC in Qatar from 2010 to 2020 ranged from 5.3 to 7.2 per 100,000 population, with an average of 5.79 per 100,000 population over this period. The overall prevalence among males was 65.6%. The incidence of CRC in young patients was approximately 1 in every four patients (24.8%). Males comprised almost two-thirds of the entire CRC cohort, yCRC, as well as the old-onset CRC cohort. The poorly differentiated CRC (including mucinous and signet ring features) was more prevalent in group 1 compared to group 2 (21.2% vs. 8%) (p = 0.001). Advanced CRC stages (III, IV) were significantly higher among the yCRC patients, with 63.3% of patients in group 1 diagnosed with advanced stages, compared to 59.6% (p = 0.001). Young patients with CRC were found to have more rectal involvement, with 35.6% of patients ≤ 45 years old compared to 23.9% in patients > 45 years old (p = 0.001).</p><p><strong>Conclusion: </strong>The reported incidence rate is approximately one-quarter of the newly diagnosed patients in Qatar. Patients with yCRC have a more aggressive and poorly differentiated histological type. The incidence of rectal cancer is higher in younger patients. Public awareness and screening policy have been implemented for better management.</p>","PeriodicalId":23856,"journal":{"name":"World Journal of Surgical Oncology","volume":"23 1","pages":"364"},"PeriodicalIF":2.5000,"publicationDate":"2025-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12512660/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Journal of Surgical Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12957-025-04010-x","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Colorectal cancer (CRC) incidence is reported to be declining overall in many countries but growing among young adults. The updated American Cancer Society (ACS) guidelines recommend screening starting at age 45 years. We sought to evaluate population-level trends in young colorectal cancer (yCRC) epidemiology in Qatar, a country in the Middle East.
Methods: Between January 2010 and December 2020, we included 1529 patients from the National Registry Database with a 5-year follow-up. The patients were divided into two groups. Group 1 (n = 380, ≤ 45 years) and group 2 (n = 1149, > 45). The epidemiological and clinicopathological features were analyzed and compared in the two groups.
Results: The annual incidence rate of CRC in Qatar from 2010 to 2020 ranged from 5.3 to 7.2 per 100,000 population, with an average of 5.79 per 100,000 population over this period. The overall prevalence among males was 65.6%. The incidence of CRC in young patients was approximately 1 in every four patients (24.8%). Males comprised almost two-thirds of the entire CRC cohort, yCRC, as well as the old-onset CRC cohort. The poorly differentiated CRC (including mucinous and signet ring features) was more prevalent in group 1 compared to group 2 (21.2% vs. 8%) (p = 0.001). Advanced CRC stages (III, IV) were significantly higher among the yCRC patients, with 63.3% of patients in group 1 diagnosed with advanced stages, compared to 59.6% (p = 0.001). Young patients with CRC were found to have more rectal involvement, with 35.6% of patients ≤ 45 years old compared to 23.9% in patients > 45 years old (p = 0.001).
Conclusion: The reported incidence rate is approximately one-quarter of the newly diagnosed patients in Qatar. Patients with yCRC have a more aggressive and poorly differentiated histological type. The incidence of rectal cancer is higher in younger patients. Public awareness and screening policy have been implemented for better management.
期刊介绍:
World Journal of Surgical Oncology publishes articles related to surgical oncology and its allied subjects, such as epidemiology, cancer research, biomarkers, prevention, pathology, radiology, cancer treatment, clinical trials, multimodality treatment and molecular biology. Emphasis is placed on original research articles. The journal also publishes significant clinical case reports, as well as balanced and timely reviews on selected topics.
Oncology is a multidisciplinary super-speciality of which surgical oncology forms an integral component, especially with solid tumors. Surgical oncologists around the world are involved in research extending from detecting the mechanisms underlying the causation of cancer, to its treatment and prevention. The role of a surgical oncologist extends across the whole continuum of care. With continued developments in diagnosis and treatment, the role of a surgical oncologist is ever-changing. Hence, World Journal of Surgical Oncology aims to keep readers abreast with latest developments that will ultimately influence the work of surgical oncologists.